GSK, EvoGenix begin second project on antibodies

08/16/2007 | Age (Melbourne, Australia), The

Australian biotech EvoGenix Ltd. said it has begun the second of three proposed projects with U.K.-based GlaxoSmithKline involving technologies used to develop antibodies for the market. The latest collaboration will attempt to "improve the properties of either an antibody or a protein to ... increase the effectiveness of drugs," EvoGenix CEO Dr. Merilyn Sleigh said.

View Full Article in:

Age (Melbourne, Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ